Kondo, Keiichi
Brigham and Women's Hospital · Harvard University · Dana-Farber Cancer Institute · Dana-Farber Brigham Cancer Center
4 papers on CoChatORCID 0000-0001-5809-751X
Most cited papers
- Verified
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science
Cancer, Hypoxia, and MetabolismUbiquitin and proteasome pathways
Cited by 4,735
- Verified
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell
Cancer, Hypoxia, and MetabolismRenal cell carcinoma treatment
Cited by 761
- Verified
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology
Cancer, Hypoxia, and MetabolismRenal cell carcinoma treatment
Cited by 611
- Verified
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
Ivan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., et al. (2002) · Proceedings of the National Academy of Sciences
Cancer, Hypoxia, and MetabolismErythropoietin and Anemia Treatment
Cited by 561
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free